Merck & Co., US58933Y1055

Merck and Co. stock gains 0.94 percent ahead of the open

Published on 09/23/2026 at 07:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 22, 2026, Merck and Co. stock rose 0.94 percent to USD 150.91, while the Dow Jones fell 0.36 percent. Healthcare news and a Cantor Fitzgerald rating update shaped attention before the open.

Photorealistic wide-angle view of a modern oncology research laboratory. A scientist in white lab coat examines cancer cell slides under a fluorescence microscope. Amber glass vials with pharmaceutical compounds line the stainless steel bench. Biosafety c
Merck US58933Y1055 Onkologie-Labor: Wissenschaftler am Mikroskop analysiert Krebszellen, mehrere Wirkstoff-Vials stehen auf der Werkbank, Illustration mit AI erstellt.

Merck and Co. stock closed at USD 150.91 on the NYSE on September 22, 2026, up 0.94 percent. The gain contrasted with a 0.36 percent decline in the Dow Jones Industrial Average, which closed at 51,863.69 on the same session date.

September 22, 2026 in numbers

Merck and Co., Inc. (ISIN US58933Y1055, NYSE: MRK) opened at USD 148.69 and reached an intraday high of USD 153.52, according to dated market data. Trading volume reached 720,345 shares by the reported update. The session performance also followed a Cantor Fitzgerald reiteration of a Neutral rating with a USD 120.00 price target, as Investing.com reported on September 22, 2026.

September 23, 2026 outlook

Healthcare-related developments remain relevant after three Merck abstracts were accepted for the October ESMO conference, according to The Motley Fool. The US calendar also includes preliminary September manufacturing and services PMI data at 9:45 p.m. ET and EIA oil inventory data at 10:30 p.m. ET, as reported by Sina Finance.

Disclaimer...

en | US58933Y1055 | MERCK & CO. | boerse | 70163270 | bgmi